Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary be.well technology platform, is working with experts and leaders in the poultry industry to launch a rapid, accurate, in-the-field multiplex panel to test for all relevant strains of avian influenza, initially focusing on Group A, H5, H7, and H9. To help codevelop and distribute the tests, Alveo has partnered with industry leaders x-OvO, Royal GD, and Pharmsure International Ltd. Joining us to tell us more is Alveo Technologies CEO Shaun Holt.